Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01491737
Brief Title: A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer (PERTAIN)

First Submitted : December 6, 2011
First Submitted that Met QC Criteria : December 12, 2011
First Posted : December 14, 2011 (Estimate)

Results First Submitted : May 11, 2017
Results First Submitted that Met QC Criteria : May 11, 2017
Results First Posted : June 7, 2017

Last Update Submitted that Met QC Criteria : October 6, 2020
Last Update Posted : October 28, 2020